In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

You couldn’t help but feel for C.J. Stroud after he watched his wide receiver Tank Dell go down with another season-ending injury. Stroud broke down, visibly emotional as Dell was put into the ...

Eli Lilly is experiencing some challenges with supply and demand for its hit weight loss treatments. This is a near-term issue and the company made several investments to ensure a more robust long ...

CJ Stroud was in shambles as he watched teammate Tank Dell get carted off the field Saturday with a knee injury. Stroud’s Houston Texans were trailing the Kansas City Chiefs 17-10 early in the ...

but the latest updates give Eli Lilly the upper hand in the near and medium term. However, I also think that the valuation differential to Novo Nordisk already reflects that, and that the company ...

The Village of Pleasant Prairie Plan Commission on Monday approved the preliminary site and operational plans for the proposed expansion of the Eli Lilly and Company facility, located at 10300 ...

Like Leqembi, Lilly's Kisunla is designed to clear an Alzheimer ... patients experiencing potentially serious brain swelling, the company said. Additionally, unlike Leqembi, Kisunla has finite ...

As a result, the company gains more resources to boost innovation and still maintain EBITDA growth. Eli Lilly's growth strategy is multi-layered, a mix of in-house innovation and acquisitions and ...

Pharmaceutical giant Eli Lilly (NYSE: LLY) is having a moment right now. Over the last two years the company has made a splash in the weight loss space thanks to its one-two punch of blockbuster ...

See Correction/Clarification at the end of this article. Eli Lilly is the maker of high-in-demand injectable pharmaceuticals like Mounjaro, used for the treatment of diabetes and weight loss.